Eroom's law

Eroom's law is the observation that drug discovery is becoming slower and more expensive over time, despite improvements in technology, such as high-throughput screening, biotechnology, combinatorial chemistry, and computational drug design. This trend was first observed in the 1980s. The cost of developing a new pharmaceutical drug roughly doubles every nine years (inflation-adjusted).

The name Eroom's law is a deliberate reversal of Moore's law, which describes the exponential advancement of transistor technology over time. By contrast, Eroom's law highlights the stagnation and increasing costs in pharmaceutical research and development (R&D).

Observations and Implications

Eroom's law suggests that, despite advances in medical science and technology, the process of discovering and bringing new drugs to market has become less efficient over time. The trend has significant implications for:

• Pharmaceutical industry profitability – Increasing costs put pressure on pharmaceutical companies.
• Drug pricing – Higher R&D costs contribute to expensive prescription medications.
• Innovation in drug development – Companies must find new strategies to improve efficiency.

Contributing Factors

Several factors contribute to the increasing costs and inefficiency in drug discovery:

• Regulatory burden – Stricter clinical trial requirements increase development time.
• Efficacy challenges – Many new drug candidates fail due to lack of effectiveness.
• Rising complexity – Modern drugs often target complex biological pathways, requiring more extensive research.
• "Better than the Beatles" problem – New drugs must outperform existing, well-established treatments.
• Economic pressures – The high cost of failure in late-stage drug trials adds to the overall expenses.

Contrasts with Moore's Law

• Moore's law predicts that the number of transistors on an integrated circuit doubles approximately every two years, leading to rapid technological advancements.
• Eroom's law, by contrast, describes an inverse trend in drug development, where costs and time increase instead of decrease.

Strategies to Address Eroom's Law

Efforts to counteract the trend of Eroom's law include:

• AI-driven drug discovery – Using artificial intelligence and machine learning to accelerate target identification and drug screening.
• Adaptive clinical trials – Designing more flexible and efficient trial methodologies.
• Collaboration between industry and academia – Improving knowledge sharing and reducing redundancy in biomedical research.
• Regulatory reforms – Streamlining approval processes without compromising safety.
• Precision medicine – Developing more targeted therapies to increase success rates.

Related Pages

• Drug discovery
• Pharmaceutical industry
• Clinical trials
• Moore's law
• Biomedical research
• Artificial intelligence in drug discovery
• Pharmaceutical pricing

See Also

• Biomedical innovation
• Translational medicine
• Computational drug design
• High-throughput screening